Postmarketing surveillance For Investigating success in achieving clinical and functional Remission and Sustaining efficacy with Tocilizumab in BIOlogics naive RA patients.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 11 Jul 2016

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

08 Jul 2016 Status changed from active, no longer recruiting to completed.
07 Jul 2016 Planned End Date changed from 28 Feb 2014 to 29 Sep 2014.
15 Jun 2015 According to a Chugai pharmaceuticals media release, data from this trial were presented at the European League Against Rheumatism Annual Congress (EULAR 2015).

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com